Clinical Pharmacokinetics of CyclophosphamideMilly E. de Jonge, Jos H. Beijnen, Alwin D. R. Huitema et al.|Clinical Pharmacokinetics|2005Cited by 451
Doxorubicin‐induced skeletal muscle atrophy: Elucidating the underlying molecular pathwaysAnouk E. Hiensch, Anne M. May, Yvonne Wengström et al.|Acta Physiologica|2019Cited by 122
Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapyMarkus Joerger, Jan H.M. Schellens, Valerie D. Doodeman et al.|Cancer Chemotherapy and Pharmacology|2015Cited by 55
Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexateMarkus Joerger, Alwin D. R. Huitema, Andrés J.M. Ferreri et al.|British Journal of Clinical Pharmacology|2011Cited by 36